INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Site Engagement Doesn't Start At First Patient In
Site engagement starts long before enrollment. Explore how well-designed investigator meetings can set the tone, build trust, and give site teams the momentum they need to deliver.
-
The Bioanalysis Report You Actually Get Back Fast
Manual bioanalysis variability creates data noise. Automation replaces inconsistencies with repeatable processes that boost precision, support compliance, and deliver more reliable results.
-
Community-Focused Site Networks Transforming Clinical Trials
Leveraging a site network has proven to ease study enrollment, contracting, and budgeting, while also reducing overall study cost and timelines.
-
The Rescue Option: Course Correcting Struggling Clinical Trials
The willingness to seek expert support from Rescue CROs when clinical trials face critical challenges is not a sign of weakness but a demonstration of accountability and commitment to excellence.
-
Uncovering The Root Cause Of Clinical Trial Troubles12/10/2024
Discover essential strategies to prevent clinical trials from reaching a crisis while gaining a deeper understanding of the importance of addressing systemic issues early.
-
Meeting Regulatory And Patient Needs By Improving Clinical Trial Access3/26/2026
Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.
-
DCTs And Community-Based Research Execution And Compliance5/28/2025
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
-
Avoid The Wrecking Ball: Targeted Solutions For Struggling Trials9/30/2025
In this presentation, our expert panel introduces the concept of scaffolding — a targeted reinforcement strategy designed to strengthen trials from the inside out.
-
The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials5/9/2025
Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
-
Discover comprehensive clinical to commercial scale manufacturing services that deliver true life-cycle management for sterile drug products that bring treatments to patients with efficiency and quality.
-
The success of your clinical trial hinges on the patients you recruit. When you can’t find and enroll the right patients at the right time, you may experience go-to-market delays and financial losses. With AutoCruitment, you can secure the patients you need, complete your trial on time, and improve your study outcomes.
-
Accelerate your clinical trials with an expansive network of over 2,000 high-quality, trusted clinical trial sites across Australia, New Zealand, United States and Canada.
-
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.